TREACE MEDICAL CONCEPTS, INC.·4

May 13, 7:30 PM ET

BAKEWELL JOHN K 4

4 · TREACE MEDICAL CONCEPTS, INC. · Filed May 13, 2024

Insider Transaction Report

Form 4
Period: 2024-05-10
Transactions
  • Purchase

    Common Stock

    2024-05-10$4.57/sh+130,000$594,620135,048 total
Holdings
  • Common Stock

    (indirect: By Trust)
    92,300
  • Common Stock

    (indirect: By Trust)
    250,000
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.425 to $4.6186, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  • [F2]Includes 2,753 restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4